PRMSE: announced the appointment of Guillaume Calmon, as Chief Technology Officer (CTO). Guillaume brings more than 25 years of experience in Health Tech R&D and leadership to the role.

Explore these links for in-depth information on the current state of radiology, workforce issues, and the latest scientific research on lung cancer screening.

Join us in this journey as we introduce PRMSE and our mission to make early lung cancer detection a reality for everyone.